Daclizumab
Generic Name: daclizumab
Manufactured by BIOGEN. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DACLIZUMAB (150MG/ML). Application: BLA761029.
Overview
Manufactured by BIOGEN. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DACLIZUMAB (150MG/ML). Application: BLA761029.
Dosage
Available as injectable for injection use.
Related Medications
Virox
virox
Non-Standardized Food Allergenic Extract [EPC]
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Elbasvir And Grazoprevir
elbasvir and grazoprevir
Hepatitis C Virus NS5A Inhibitor [EPC]
11 DESCRIPTION ZEPATIER is a fixed-dose combination tablet containing elbasvir and grazoprevir for oral administration. Elbasvir is an HCV NS5A inhibitor, and grazoprevir is an HCV NS3/4A protease inhibitor. Each tablet contains 50 mg elbasvir and 100 mg grazoprevir.
Telmisartan And Hydrochlorothiazide
telmisartan and hydrochlorothiazide
Thiazide Diuretic [EPC]
11 DESCRIPTION Telmisartan and Hydrochlorothiazide Tablets, USP are a combination of telmisartan, USP an orally active angiotensin II antagonist acting on the AT 1 receptor subtype, and hydrochlorothiazide, USP a thiazide diuretic. Telmisartan, USP a non-peptide molecule, is chemically described as 4’-[[4-methyl- 6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl] methyl]-2-biphenylcarboxylic acid.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.